This library indexes the peptide research content published on this site, organized by compound. Each entry links to a page reviewing the published literature on that compound, drawn from preclinical, animal, and clinical sources where they exist. Depth of coverage varies: some compounds have a single overview, others have more than one page examining different parts of the literature.
BPC-157
- BPC-157: What the Research Actually Shows
Reviews animal studies and cell models on BPC-157 in connective tissue repair, with a focus on tendon and ligament healing mechanisms. - BPC-157 FDA Status 2026: What Researchers Need to Know
Explains the current regulatory classification and how enforcement actions affect research-use-only suppliers versus compounding pharmacies.
BPC-157 and TB-500
- BPC-157 + TB-500 Blend: What the Research Actually Shows
Reviews the separate literature on each compound and notes that no published study has examined the two combined as a single formula. - BPC-157 and TB-500: Research Overview
Looks at the complementary mechanisms described in published research, tissue signaling and cell migration, across musculoskeletal research models.
Cagrilintide
- Cagrilintide: What the Research Actually Shows
Reviews early-stage trial and animal mechanism data on this long-acting amylin analog studied in metabolic research.
CJC-1295
- CJC-1295: What the Research Actually Shows
Reviews trial and animal literature on this GHRH analog, focused on growth hormone and IGF-1 signaling. - CJC-1295 With DAC vs Without DAC
Compares the pharmacokinetic profile of the two variants, including half-life and growth hormone release patterns described in the literature.
CJC-1295 and Ipamorelin
- CJC-1295 + Ipamorelin: What the Research Actually Shows
Reviews the individual research bases for each compound and notes that no published study has tested the two together.
Epithalon
- Epithalon: What the Research Actually Shows
Reviews cell and animal literature on telomere length, telomerase activity, and aging markers, noting the absence of human longevity trials. - Epithalon (Epitalon): A Research Deep-Dive on the Pineal Tetrapeptide
Surveys laboratory research on this synthetic tetrapeptide across telomerase activity, circadian regulation, and longevity-linked gene expression.
GHK-Cu
- GHK-Cu: What the Research Actually Shows
Reviews preclinical cell and animal literature on this copper-binding tripeptide in tissue remodeling and gene expression. - GHK-Cu (Copper Tripeptide): A Research Compound Deep-Dive
Surveys in vitro research on collagen synthesis and extracellular matrix remodeling pathways.
HCG
- HCG: What the Research Actually Shows
Reviews clinical literature on human chorionic gonadotropin in testosterone production and testicular function research.
Hexarelin
- Hexarelin Research: Growth Hormone Secretagogue and Cardioprotective Properties
Examines literature on receptor activity and on cardiac tissue effects described independent of GH secretion.
IGF-1
- IGF-1: What the Research Actually Shows
Reviews literature on IGF-1 in growth hormone deficiency research and its mechanisms in animal models. - IGF-1 LR3: What the Research Actually Shows
Reviews use as a cell-culture reagent and mixed findings from animal model studies, noting the absence of human trials.
Ipamorelin
- Ipamorelin: What the Research Actually Shows
Reviews the mechanism and early animal literature on this growth hormone secretagogue, including limited human pharmacokinetic data. - Ipamorelin vs CJC-1295: Differences and Research Applications
Compares the receptor mechanisms of the two compounds and explains why researchers study them together.
Kisspeptin-10
- Kisspeptin-10 Research: HPG Axis Regulation and Reproductive Biology
Examines the role described in the hypothalamic-pituitary-gonadal axis and its use in reproductive endocrine research.
KPV
- KPV: What the Research Actually Shows
Reviews preclinical literature on this alpha-MSH-derived tripeptide in animal and cell models of intestinal inflammation. - KPV (Lys-Pro-Val): The Alpha-MSH Tripeptide Fragment Drawing Research Attention
Surveys laboratory research on inflammation signaling and intestinal barrier studies.
MOTS-c
- MOTS-c: What the Research Actually Shows
Reviews animal and cell culture literature on this mitochondrial-DNA-encoded peptide in metabolism and insulin signaling. - MOTS-c: The Mitochondria-Derived Peptide at the Center of Metabolic Research
Examines AMPK pathway activity and its emerging place in metabolic and aging research.
NAD+
- NAD+: What Researchers Have Actually Studied
Reviews literature on the role in cellular energy production and early trial data on precursor compounds. - NAD+ Research: Cellular Energy and Longevity Applications
Examines function in sirtuin activity and DNA repair, and compares NMN and NR as precursor strategies discussed in the literature.
PT-141
- PT-141: What the Research Actually Shows
Reviews phase 3 trial literature on bremelanotide melanocortin receptor activity and the sexual-desire measures studied.
Retatrutide
- Retatrutide: What the Research Actually Shows
Reviews phase 2 trial literature on this triple agonist across body weight, glycemic markers, and liver fat.
Selank
- Selank: What the Research Actually Shows
Reviews the largely Russian-language literature on anxiety and cognitive measures studied. - Selank: A Research Look at the Tuftsin-Analogue Heptapeptide
Surveys preclinical literature across GABAergic signaling and immune pathways.
Semax
- Semax: What the Research Actually Shows
Reviews Russian-literature studies on neuroprotective activity in stroke and brain injury models.
Sermorelin
- Sermorelin Research: Growth Hormone Secretagogue and Pituitary Function
Examines literature on this GHRH analog pituitary signaling mechanism and its comparison to related compounds.
SS-31
- SS-31: What the Research Actually Shows
Reviews trial literature on this mitochondria-targeting peptide in rare mitochondrial disorder and heart failure research. - SS-31 (Elamipretide): A Mitochondria-Targeting Peptide Under Active Research
Examines interaction with cardiolipin and its history across mitochondrial dysfunction research and clinical trials.
TB-500
- TB-500: What the Research Actually Shows
Reviews published research on Thymosin Beta-4 and its synthetic analog, focused on wound healing and blood vessel growth.
Tesamorelin
- Tesamorelin: What the Research Actually Shows
Reviews randomized trial literature on visceral fat, liver fat, and metabolic markers. - What Is Tesamorelin? A GHRH Analogue Research Profile
Examines the mechanism of action and documented research applications in visceral fat and cognitive function studies.
Thymosin Alpha-1
- Thymosin Alpha-1: What the Research Actually Shows
Reviews randomized trial literature in severe sepsis and chronic hepatitis B research. - Thymosin Alpha-1: A Research Deep-Dive Into an Immunomodulatory Thymic Peptide
Surveys laboratory immunology research on T-cell maturation and innate immune activation.
Choosing a research source
- How to Vet a Research Peptide Source
A checklist of criteria for evaluating research peptide suppliers, including named testing labs and matching lab documentation. - Best Research Peptide Vendors 2026: How to Evaluate Quality
Reviews the 2025 shakeout among research peptide suppliers and sets out criteria for evaluating vendors going forward.
Handling and storage
- Peptide Storage Temperature Guide: Lyophilized vs Reconstituted
Covers storage conditions for lyophilized material, including light sensitivity and degradation indicators.